<DOC>
	<DOCNO>NCT01256437</DOCNO>
	<brief_summary>The investigator hypothesize topical anti-inflammatory treatment could counteract inflammatory reaction induce EGFR'Is .</brief_summary>
	<brief_title>Evaluating Preventive Therapy With Oint Threolone , Synthomycine Aqua Cream Lotion , EGFR ' I Induced Acneiform Rash</brief_title>
	<detailed_description />
	<mesh_term>Cetuximab</mesh_term>
	<criteria>Patients plan initiate treatment either cetuximab , erlotinib , gefitinib panitumumab . Patients receive facial topical treatment / systemic antibiotic antiinflammatory drug 2 week prior study initiation . Known hypersensitivity ointment Synthomycine Threolone . Patients present cutaneous rash 2 week prior study initiation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2013</verification_date>
	<keyword>Acneiform eruption</keyword>
	<keyword>papulopustular</keyword>
	<keyword>EGFR</keyword>
	<keyword>cetuximab</keyword>
	<keyword>erlotinib</keyword>
	<keyword>gefitinib</keyword>
	<keyword>panitumumab</keyword>
	<keyword>eruption secondary treatment either cetuximab</keyword>
</DOC>